By Abhishek Vishnoi
MUMBAI (Reuters) - The Nifty posted its biggest percentage fall in a year on Thursday, as the prospect of an end to the U.S. stimulus programme and a weak China manufacturing survey sparked concerns foreign investors would end their recent buying spree. The Sensex fell 388 points.
The biggest concerns focused on Federal Reserve Chairman Bernanke's comments suggesting bond purchases could be scaled back if the U.S. economy improves, with falls magnified after State Bank of India slumped after disappointing quarterly earnings.
A potential early wind-down of the U.S. stimulus programme could hit Indian stocks badly, analysts have warned, as foreign institutional investors have been net buyers for 25 consecutive sessions, helping spark a rally since mid-April.
Still, analysts said prospects of the Reserve Bank of India cutting interest rates again in June after easing three times this year could help support shares.
"Indian markets were overbought and therefore we are seeing some correction. Some outflows are possible but it will be not be an exodus," said Paras Adenwala, MD & Principal Portfolio Manager, Capital Portfolio Advisors.
The Nifty fell 2.09 percent or 127.45 points, to end at 5,967.05, marking its biggest daily percentage fall since May 8, 2012.
The Sensex fell 1.93 percent or 387.91 points, to end at 19,674.33, falling for a fourth consecutive session.
The NSE's volatility index, considered by some investors as a fear gauge, jumped as much as 8 percent to its highest level in eight months on worries about outflows even as Finance Minister P. Chidambaram said fears U.S. monetary stimulus programme reversal were unfounded.
A weak manufacturing survey from China added to concerns about a delayed recovery in the world's second-largest economy, contributing to steep share losses throughout Asia.
Blue-chips led the index falls. ICICI Bank Ltd fell 3.1 percent and Reliance Industries Ltd lost 4.2 percent.
State Bank of India slumped 7.9 percent after posting its first quarterly net profit drop in two years and missing market estimates because of lower interest income and higher provisions for loan losses.
Larsen & Toubro Ltd fell 6.3 percent, adding to Wednesday's nearly 6 percent decline, on lingering disappointment over its January-March profit and outlook out on Wednesday.
Ranbaxy Laboratories Ltd slumped 8.5 percent after majority shareholder Daiichi Sankyo Co said it believed former shareholders of the company hid information regarding U.S. regulatory probes.
Wockhardt Ltd fell 20 percent to its lowest level in more than seven months after the U.S. drug regulator published an "import alert" on one of its manufacturing facilities.
However, among stocks that gained, Oracle Financial Services Software Ltd rose 8.9 percent after a higher-than-expected response to its share sale squeezed out short positions in the futures market, dealers said.
(Editing by Sunil Nair)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
